Raymond James maintains UMB Financial stock with $135 target

Published 30/05/2025, 11:48
Raymond James maintains UMB Financial stock with $135 target

On Thursday, Raymond (NSE:RYMD) James analyst David Long reaffirmed a Strong Buy rating on UMB Financial (NASDAQ:UMBF), with a price target of $135.00. The $7.88 billion market cap financial institution, currently trading at $103.79, has demonstrated strong financial performance with a P/E ratio of 13.81. According to InvestingPro data, eight analysts have recently revised their earnings upward for the upcoming period, suggesting growing confidence in the company’s prospects. The financial services company recently announced the pricing of a $300 million offering of Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B, with a yield of 7.750%. The offering is scheduled to settle on June 12, 2025, and dividends are to be paid quarterly starting January 15, 2026. This move aligns with UMB Financial’s impressive dividend track record - InvestingPro data shows the company has maintained dividend payments for 55 consecutive years and raised them for 32 straight years.

The new Series B stock will have a fixed interest rate period from the settlement date until July 15, 2030. After this date, the interest rate will reset to an annual rate equal to the five-year treasury rate plus a 3.743% spread, with subsequent resets occurring every five years. According to Long, UMB Financial aims to use the proceeds from this offering to redeem certain securities that are set to reprice at higher rates in the coming months.

UMB Financial is preparing for the redemption of two specific issuances. The first is $111 million of Series A stock with a 7.00% yield, which is due to reprice on July 15, 2025, to a yield of 10.695%, marking a 3.695% increase. The second is $200 million of fixed-to-fixed rate subordinated notes due in 2030, currently yielding 3.70%. These notes are expected to reprice on September 17, 2025, to a yield of 7.457%, a 3.757% increase. Both securities are eligible for redemption on their respective reset dates.

Long believes that the redemption of the two higher-repricing issuances using the Series B offering proceeds could be roughly 1% dilutive to UMB Financial’s EPS for the year 2026. The strategic financial move is anticipated to manage the company’s cost of capital amidst upcoming repricing events. InvestingPro’s comprehensive analysis indicates the company maintains a "Fair" overall financial health score, with particularly strong marks in profitability and growth metrics. For deeper insights into UMB Financial’s valuation and growth prospects, investors can access the detailed Pro Research Report, available exclusively to InvestingPro subscribers.

In other recent news, UMB Financial Corporation has initiated a public offering of depositary shares representing a fractional interest in its Series B Preferred Stock. The funds raised are intended for general corporate purposes, which may include redeeming its Series A Preferred Stock and retiring some subordinated notes due in 2030. Additionally, UMB Bank, a subsidiary of UMB Financial, has expanded its Corporate Trust and Agency Services group by opening a new office in Costa Mesa, California. This expansion includes the addition of thirteen professionals from Wilmington Trust, enhancing UMB’s presence on the West Coast.

In analyst updates, Raymond James has maintained a Strong Buy rating for UMB Financial, with a price target of $135, citing the successful integration of Heartland as a key factor for expected earnings growth. Conversely, Citi has adjusted its price target for UMB Financial to $109, maintaining a Neutral rating due to concerns over the company’s credit profile and a rise in Commercial & Industrial Net Charge-Offs. At the recent annual shareholder meeting, UMB Financial reported the election of 16 directors and the approval of executive compensation, reflecting strong support from shareholders. The ratification of KPMG LLP as the company’s independent auditor for 2025 was also overwhelmingly approved.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.